Virtu Financial’s Revolution Medicines RVMD Stock Holding History

Virtu Financial’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2,918	Closed	-$284K	–	2155
2026 Q1	$284K	Buy	+2,918	New	+$295K	0.01%	839
2025 Q3	–	Sell	-43,005	Closed	-$1.58M	–	1999
2025 Q2	$1.58M	Buy	+43,005	New	+$1.65M	0.08%	220
2025 Q1	–	Sell	-6,224	Closed	-$272K	–	1943
2024 Q4	$272K	Buy	+6,224	New	+$314K	0.01%	747
2023 Q4	–	Sell	-13,457	Closed	-$372K	–	1942
2023 Q3	$372K	Buy	+13,457	New	+$399K	0.04%	424

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Virtu Financial's RVMD Position: Q2 2026 in Review

Virtu Financial sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 2,918 shares — an estimated $284K sold.

Virtu Financial first reported a position in RVMD in Q3 2023 and held it in 4 quarters. The position peaked at $1.58M in Q2 2025. 693 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Virtu Financial reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
Virtu Financial sold 2,918 Revolution Medicines shares in Q2 2026, an estimated $284K.
Virtu Financial first reported a position in Revolution Medicines in Q3 2023 and held it in 4 quarters.
Virtu Financial's Revolution Medicines position peaked at $1.58M in Q2 2025.
693 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.